Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948
Go back to Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948| (NASDAQ: NRIX) | Delayed: 26.13 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.14 | 52 Week High | $ | |||
| Open | $25.42 | 52 Week Low | $ | |||
| Day High | $26.42 | P/E | N/A | |||
| Day Low | $25.36 | EPS | $ | |||
| Volume | 1,287,860 | |||||

